Skip to main content

Table 3 Grade 3 and 4 Toxicities observed in 52 patients (174 courses) according to CTCAE 4.0

From: Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?

Toxicity

Grade 3

Grade 4

events (%)

Patients (%)

events (%)

Patients (%)

Blood and lymphatic system disorders

 Bone marrow hypocellular

  Neutropenia

55 (31.6)

22 (42.3)

0

0

  Thrombocytopenia

61 (35.1)

24 (46.2)

5 (2.9)

4 (7.7)

  Anemia

52 (29.9)

16 (30.8)

0

0

  Febrile neutropenia

3 (1.7)

3 (5.8)

0

0

Gastrointestinal disorders

 Nausea

2 (1.1)

2 (3.8)

0

0

 Vomiting

2 (1.1)

2 (3.8)

0

0

 Diarrhea

1 (0.6)

1 (1.9)

0

0

 Mucositis oral

1 (0.6)

1 (1.9)

0

0

Hepatic disorders

 Elevated ALT/AST

5 (2.9)

4 (7.7)

0

0

Metabolism and nutrition disorders

 Hypokalemia

2 (1.1)

2 (3.8)

0

0

 Hypocalcemia

1 (0.6)

2 (3.8)

0

0

 Hyperglycemia

4 (2.3)

2 (3.8)

0

0